header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-2379
Fish name: nz101Tg; s843Tg
Genotype: nz101Tg; s843Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by nz101Tg; s843Tg
No data available
GENE EXPRESSION
Gene expression in nz101Tg; s843Tg
Protein expression No data available
PHENOTYPE
Phenotype in nz101Tg; s843Tg
Phenotype Conditions Figures
intestinal lymphatic network lymphangiogenesis increased process quality, abnormal chemical treatment: metronidazole, chemical treatment: 2,4,6-trinitrobenzenesulfonic acid Fig. 5 with image from Okuda et al., 2015
intestinal lymphatic network lymphangiogenesis increased process quality, abnormal chemical treatment: dextran sulfate Fig. 1 with image from Okuda et al., 2015
intestinal lymphatic network lymphangiogenesis increased process quality, abnormal chemical treatment: 2,4,6-trinitrobenzenesulfonic acid Fig. 1 with image from Okuda et al., 2015
intestinal lymphatic network lymphangiogenesis process quality, ameliorated chemical treatment: 2,4,6-trinitrobenzenesulfonic acid, chemical treatment: mesalamine Fig. 1 with image from Okuda et al., 2015
intestinal lymphatic network lymphangiogenesis process quality, ameliorated chemical treatment: dextran sulfate, chemical treatment: mesalamine Fig. 1 with image from Okuda et al., 2015
intestinal lymphatic network lymphangiogenic sprout amount, ameliorated chemical treatment: dextran sulfate, chemical treatment: mesalamine Fig. 1 with image from Okuda et al., 2015
intestinal lymphatic network lymphangiogenic sprout amount, ameliorated chemical treatment: 2,4,6-trinitrobenzenesulfonic acid, chemical treatment: mesalamine Fig. 1 with image from Okuda et al., 2015
intestinal lymphatic network lymphangiogenic sprout increased amount, abnormal chemical treatment: 2,4,6-trinitrobenzenesulfonic acid Fig. 1 with image from Okuda et al., 2015
intestinal lymphatic network lymphangiogenic sprout increased amount, abnormal chemical treatment: dextran sulfate Fig. 1 with image from Okuda et al., 2015
intestinal lymphatic network lymphangiogenic sprout increased amount, abnormal chemical treatment: metronidazole, chemical treatment: 2,4,6-trinitrobenzenesulfonic acid Fig. 5 with image from Okuda et al., 2015
trunk lymphangiogenesis process quality, normal chemical treatment: 2,4,6-trinitrobenzenesulfonic acid Fig. 1 with image from Okuda et al., 2015
trunk lymphangiogenesis process quality, normal chemical treatment: dextran sulfate Fig. 1 with image from Okuda et al., 2015

CITATIONS  (7)